Tumor Models Archives - Page 9 of 11

Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic...

KRAS mutant proteins that drive cancer development are highly similar in sequence and structure. Direct inhibitors are most likely to...

Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including: In vitro induced Palbociclib resistant MCF-7 cell line...

In this week’s installment of our “How Does It Work?” video series, we explore Antibody Drug Conjugates. Monoclonal antibodies are...

WuXi AppTec xenograft and syngeneic tumor models in rats and CD47-related in vitro assay platform

WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to...

Lung cancer is the leading cause of cancer-related death worldwide. Nearly 80% of lung cancers are non-small cell lung cancer...

Non-CNS metastatic brain cancer is approximately 10 times more common than CNS cancer. Lung cancer and breast cancer account for...

Knowledge Library